House: Johnson & Johnson has received approval from the U.S. Food and Drug Administration (FDA) for IMAAVY (nipocalimab-aahu) ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

Neil Young's new song calls on legacy U.S. automakers to step up and challenge Tesla’s dominance in the electric vehicle space.

The US Food and Drug Administration has approved nipocalimab-aahu, a new FcRn- blocking monoclonal antibody, for the treatment of generalized myasthenia gravis.

The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's drug to treat a type of muscle-weakening ...

Nipocalimab-aahu is a human immunoglobulin G1 monoclonal antibody that binds with high affinity to the neonatal Fc receptor, resulting in the reduction of circulating IgG levels.

Donald Trump and his administration have waged an all-out assault on America's founding principles over the president's first 100 days in office.

The company has predicted that Imaavy — now approved for myasthenia gravis — could eventually earn more than $5 billion in ...

More than 20,000 jobs were eliminated, billions of dollars in scientific research has been threatened or paused, and a budget ...

Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...

The US FDA has approved Johnson & Johnson's drug to treat patients aged 12 years and older with an immune-mediated disorder ...

After a Consumer Reports study found toxic chemicals in baby formulas, Sen. Jon Ossoff is pressing Abbott Nutrition and Mead ...